Study details a link between inflammation and cancer
Timing of inflammation determines whether potentially cancerous mutations may arise.
Timing of inflammation determines whether potentially cancerous mutations may arise.
Jeff Gore’s work with baker’s yeast helps ecologists respond to trends, like vanishing fisheries and collapsing honeybee colonies.
Rhodes Scholar Elliot Akama-Garren seeks to harness the power of the immune system to combat cancer.
When RNA-binding proteins are turned on, cancer cells get locked in a proliferative state.
Nanoparticles that enable both MRI and fluorescent imaging could monitor cancer, other diseases.
Bhatia recognized for work developing low-cost, noninvasive diagnostics for colon cancer.
Eisen was a pioneering immunologist and longstanding member of MIT’s cancer research community.
New approach could kill tumor cells in the brain more effectively and avoid side effects.
New genome-editing technique enables rapid analysis of genes mutated in tumors.
Novel device that stays in the bladder and slowly releases drugs sells to pharmaceutical giant.
Senior Christina Lalani applies lessons she learned from karate to global health disparities.
Patients show boost in certain amino acids years before diagnosis of pancreatic cancer.
Time-saving tool takes advantage of CRISPR gene-editing technology.
With some tinkering, a deadly protein becomes an efficient carrier for antibody drugs.